We are live on ! Find out more
CLLS

Cellectis

48 hedge funds and large institutions have $219M invested in Cellectis in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

21% more capital invested

Capital invested by funds: $181M → $219M (+$37.5M)

12% more funds holding

Funds holding: 4348 (+5)

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

Holders
48
Holders Change
+5
Holders Change %
+11.63%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
13
Reduced
12
Closed
10
Calls
Puts
Net Calls
Net Calls Change

CLLS Hedge Fund Activity: Q4 2015 in Review

48 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2015, worth a combined $219M — up 21% from $181M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CLLS positions and 10 closed out — a net gain of 5 holders — while 13 added to existing stakes and 12 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $13.9M. The largest seller was BlackRock Advisors, cutting an estimated $7.58M.

  • 48 institutional investors held Cellectis (CLLS) as of Q4 2015, up from 43 in Q3 2015.
  • Funds reported $219M of Cellectis stock for Q4 2015, up 21% quarter-over-quarter.
  • 15 funds opened new Cellectis positions in Q4 2015 and 10 closed out, a net change of +5 holders.
  • The largest Cellectis buyer in Q4 2015 was Cormorant Asset Management, an estimated $13.9M added.
  • The largest Cellectis seller in Q4 2015 was BlackRock Advisors, an estimated $7.58M sold.

Based on aggregated 13F filings for Q4 2015.